This study investigates advanced solid tumors. The purpose of this study is to evaluate AST-001 as a single agent in patients with these tumors.
This study evaluates the safety, tolerability, and preliminary effectiveness of the investigational medication. The study also looks at how the medicine is processed in the body.
- Who can participate: Adults aged 18 to 70 with a confirmed solid malignancy that is metastatic or cannot be surgically removed may participate. Participants should have a good performance status and adequate organ function.
- Study details: Participants will take AST-001 as a single agent.